The PGA Tour heads to the Midwest this week for the John Deere Classic at TPC Deere Run in Silvis, Ill. Originally known as the Quad Cities Open when it debuted in 1971, the tournament found its ...
Duty-free giant Avolta said it is buying the business of rival DFS in Okinawa, Japan, entering the East Asian country for the first time. The deal covers DFS's operations at Okinawa's Naha Airport and ...
The PGA TOUR heads to one of golf’s ultimate survival tests as the U.S. Open returns to historic Shinnecock Hills Golf Club. With a 156-player field, a brutal top-60-and-ties cut line, and conditions ...
Scottie Scheffler and Collin Morikawa lead the roster for the upcoming Presidents Cup. See who else is playing for Captain Brandt Snedeker. USA TODAY Sports - Golfweek Scottie Scheffler leads 2026 ...
Barring a legal or regulatory miracle, the launch of a regulated iGaming market in Alberta will likely deal a serious blow to paid daily fantasy sports contests in the province. Alberta’s new ...
When crafting an MLB DFS strategy, one wouldn't normally be in a hurry to roster a player hitting just .232 with four homers. However, Andrew Benintendi's MLB DFS value for Monday comes not in his ...
Folks in Thoroughbred racing should stop trying to justify what Marshall Gramm did. It’s shady and inexcusable. And HISA and the FTC need to be bold and decisive in announcing how they intend to fix ...
Hideki Matsuyama has been showing signs of regaining his best form of late. Hector Vivas / Getty Images The PGA Tour heads back to Florida for the Cadillac Championship at Trump National Doral. The ...
ESPN's fantasy basketball daily cheat sheet is your pregame destination before you set your lineups for that night's games. Here you'll read our best advice for the night, including a selection of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...
SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma ...